Dr. Yin-Kun Liu
MD, PhD
Professor & Senior Liver Cancer Researcher
corporate_fareZhongshan Hospital, Fudan University, Shanghai
Yin-Kun Liu
MD, PhD
Prof. Yin-Kun Liu is a senior liver cancer researcher associated with the Liver Cancer Institute at Zhongshan Hospital, Fudan University, in Shanghai. His academic work has focused on hepatocellular carcinoma, with particular attention to the biological mechanisms behind liver cancer invasion, metastasis and postoperative recurrence.
Prof. Liu's research has contributed to translational work aimed at improving the early detection and clinical understanding of liver cancer. His studies span serum proteomics, molecular biomarkers and experimental models of metastatic hepatocellular carcinoma. He has served as a corresponding author on research evaluating CD14 and alpha-fetoprotein as complementary biomarkers, reporting that combining the two may improve identification of hepatocellular carcinoma compared with AFP alone. His work reflects a strong emphasis on translating laboratory discoveries into clinically relevant approaches for liver cancer diagnosis and precision management.
CancerFax can coordinate medical-report review and consultation support for international patients seeking evaluation at the Liver Cancer Institute, subject to hospital availability and case acceptance.
Why Consider Prof. Yin-Kun Liu?
Prof. Liu brings decades of focused academic expertise in the biology and diagnosis of hepatocellular carcinoma at one of China's leading liver cancer centres.
Areas of Specialization
Research and translational focus in liver cancer
Prof. Liu's academic expertise centres on the diagnosis, biology and biomarker-based understanding of hepatocellular carcinoma and related liver tumours.
Hepatocellular Carcinoma Research
Translational research into the biology, detection and behaviour of liver cancer.
- arrow_rightSerum proteomics and glycoproteomics for liver cancer
- arrow_rightCD14 and alpha-fetoprotein (AFP) as complementary HCC biomarkers
- arrow_rightMolecular biomarkers for early-stage liver cancer detection
- arrow_rightExperimental models of metastatic hepatocellular carcinoma
- arrow_rightStudy of postoperative liver cancer recurrence
- arrow_rightMechanisms of liver cancer invasion and tumour spread
Translational Liver Cancer Diagnosis
Applying laboratory research to clinically meaningful diagnostic clarification.
- arrow_rightDistinguishing hepatocellular carcinoma from chronic liver disease and cirrhosis
- arrow_rightEvaluation of early-stage liver lesions requiring further assessment
Clinical & Research Services
Evaluation, planning and second-opinion support for liver cancer
Evaluation at a specialised liver cancer centre may support patients with complex, recurrent or difficult-to-characterise liver tumours.
Liver Cancer Diagnostic Evaluation
DiagnosisReview of imaging, pathology and biomarker findings to characterise liver tumours.
Multidisciplinary Treatment Planning
MultidisciplinaryInput into team-based planning for liver-directed treatment options.
Complex & Recurrent Liver Cancer Review
Complex DiseaseEvaluation of recurrent or metastatic hepatocellular carcinoma.
Second Opinion Consultations
Second OpinionIndependent academic review of liver cancer pathology, imaging and history.
Research & Publications
Liver cancer biomarkers, proteomics and metastasis research
Prof. Liu's published research focuses on the early detection, biology and recurrence of hepatocellular carcinoma.
A more detailed publication list may be available on request via CancerFax.
Education & Training
Prof. Liu trained in medicine in Shanghai and progressed through master's and doctoral research, building a long academic career in liver cancer biology.
Clinical Experience
Prof. Liu has built a long academic career centred on hepatocellular carcinoma research at the Liver Cancer Institute, Zhongshan Hospital, Fudan University.
Languages & International
Prof. Liu's published academic work is in Mandarin and English.
CancerFax can coordinate professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support when required.
How CancerFax Helps You Access Dr. Yin-Kun Liu
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Yin-Kun Liu's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Yin-Kun Liu's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Yin-Kun Liu before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Yin-Kun Liu's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Yin-Kun Liu's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Yin-Kun Liu's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Yin-Kun Liu
Prof. Liu is a senior liver cancer researcher at the Liver Cancer Institute, Zhongshan Hospital, Fudan University, in Shanghai. His work focuses on hepatocellular carcinoma, including liver cancer biomarkers, serum proteomics, tumour metastasis and postoperative recurrence.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion connected to the Liver Cancer Institute, subject to hospital availability and case acceptance.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with the hospital, subject to availability. The final consultation format depends on the institution.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history and relevant test results. The review can help clarify the diagnosis and possible next steps, while the final consultation format and availability depend on the institution.
Treatment decisions for liver cancer may involve surgery, ablation, transarterial chemoembolisation (TACE), systemic therapy, radiotherapy or other liver-directed approaches. The appropriate plan depends on tumour stage, liver function, vascular involvement, previous treatment and the patient's overall condition, and requires review by the treating clinical team.
Connect with Yin-Kun Liu Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.